跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG - HSA Drug Approval Details
Approvals
/
HSA
/
SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG
Approved
STANDARD
SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
4bb20c3a1f6ca485
Company
Unknown
Type
Standard
Approval Details
Approval Id
4bb20c3a1f6ca485
Drug Name
SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG
Active Ingredients
Glycopyrronium Bromide 63mcg eqv Glycopyrronium
50 mcg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
4bb20c3a1f6ca485
Type
Standard
Back to HSA Approvals
